 Second-line platinum therapy patients ovarian cancer cisplatin effort incidence clinical characteristics secondary responses cisplatin-based therapy patients ovarian cancer cisplatin-based program retrospective review undertaken patients Memorial Sloan-Kettering Cancer Center equal cisplatin/carboplatin-based programs Eighty-two patients entry criteria cisplatin-free interval CFI months completion first regimen institution second cisplatin/carboplatin program assessable patients measurable disease laparotomy response complete responses S-CRs overall response rates S-CR rate duration CFI months months months Twenty-nine patients noncisplatin/carboplatin-containing treatments cisplatin programs Patients treatment months completion initial therapy response rate S-CR rate conclusion secondary responses cisplatin/carboplatin-based treatment common patients ovarian cancer agents frequency distance initial therapy